Dutch Bros Still Trades at a Premium to Starbucks and Its Peers. Is the Growth Story Already Priced In?

Dutch Bros trades at 90x trailing earnings versus Starbucks at 82x and the S&P 500 at 31x, but the company continues to execute with 7.7% 2025 comparable sales growth, 5.4 percentage points from traffic. Operating profit rose 51.9% to $161.2 million, and management expects to open at least 181 locations this year with 2026 comps growth of 3%-5%. The article is constructive on the growth story but warns the valuation remains expensive.

Analysis

The market is implicitly treating BROS as a long-duration compounding story, not a near-term earnings story, which is why the multiple stays elevated despite already-strong growth. The key second-order issue is that any premium valuation now requires not just store openings, but sustained unit economics across new geographies; if Midwest/Northeast expansion shows weaker payback curves, the multiple can compress quickly even if headline revenue keeps rising. In other words, the stock is less about this year’s comps and more about whether management can prove the concept scales without customer-acquisition friction or labor inflation.

SBUX is the lower-beta beneficiary if investors rotate toward “quality growth with less execution risk.” Its valuation is still rich, but unlike BROS it has a broader margin repair lever set and can support the multiple through traffic mix, pricing, and cost discipline rather than pure new-unit growth. That makes SBUX the more defensible way to express a consumer beverage demand thesis over the next 6-12 months, especially if the market starts to penalize names whose growth is too geographically concentrated.

The contrarian read is that the comparison itself may be misleading: BROS is being priced like a platform expansion story while SBUX is being priced like a turnaround. If BROS merely delivers guidance, the stock may go nowhere because expectations already embed a lot of success; if SBUX surprises on margin or traffic durability, its rerating potential may be larger from here than the headlines suggest. The real risk to BROS is not a demand collapse, but a normalization of growth to a still-good-but-not-elite level that exposes how much perfection is in the valuation.

Key Decisions for Investors

• Fade the relative premium by pairing long SBUX / short BROS over the next 3-6 months; use this as a valuation spread trade rather than an outright short because both names still have fundamental support.
• If initiating BROS exposure, do it via staged entries over 8-12 weeks and size small; the risk/reward is asymmetric only if new-market unit economics hold, otherwise multiple compression can offset operating growth.
• Sell out-of-the-money BROS calls against a long stock position into strength to harvest elevated implied expectations; this monetizes the premium while preserving upside if expansion execution remains strong.
• For more conservative consumer exposure, prefer SBUX on a 6-12 month horizon; downside is more anchored by cash flow and margin levers, while upside comes from continued traffic and mix improvement rather than pure store-count dependence.